188 related articles for article (PubMed ID: 9121219)
21. Bleeding secondary to the use of thrombolytic agent in a patient with recent renal lithotripsy.
Bleckley JE; Morse HG
J S C Med Assoc; 1991 Nov; 87(11):549-50. PubMed ID: 1766245
[TBL] [Abstract][Full Text] [Related]
22. [Thrombolysis in acute myocardial infarct in everyday clinical practice].
De Benedetti E; Urban P; Burgan S; Dorsaz PA; Chatelain P; Gaspoz JM; Chevrolet JC; Unger PF
Schweiz Med Wochenschr; 1997 Aug; 127(31-32):1285-90. PubMed ID: 9333939
[TBL] [Abstract][Full Text] [Related]
23. Case history: successful thrombolytic therapy in a patient with acute myocardial infarction.
Sait YR
Heart Lung; 1988 Nov; 17(6 Pt 2):782-6. PubMed ID: 3142824
[No Abstract] [Full Text] [Related]
24. Splenic hemorrhage: a complication of tissue plasminogen activator treatment.
Cheung PK; Arnold JM; McLarty TD
Can J Cardiol; 1990 Jun; 6(5):183-5. PubMed ID: 2116935
[TBL] [Abstract][Full Text] [Related]
25. Thrombolytic therapy for myocardial infarction.
Andreotti F
N Engl J Med; 1998 Feb; 338(8):546; author reply 547. PubMed ID: 9471558
[No Abstract] [Full Text] [Related]
26. Cardiac tamponade mimicking ventricular rupture after thrombolysis for acute myocardial infarction.
Imperadore F; Spagnolli W; Martinelli L; Musuraca G; De Girolamo P; Maines M; Vergara G
Minerva Cardioangiol; 2003 Aug; 51(4):417-8. PubMed ID: 12900724
[No Abstract] [Full Text] [Related]
27. Splenic hemorrhage after tissue plasminogen activator for acute myocardial infarction.
Blankenship J; Indeck M
N Engl J Med; 1991 Sep; 325(13):969. PubMed ID: 1908949
[No Abstract] [Full Text] [Related]
28. Tissue plasminogen activator in pediatric myocardial infarction.
Krendel S; Pollack P; Hanly J
Ann Emerg Med; 2000 May; 35(5):502-5. PubMed ID: 10783412
[TBL] [Abstract][Full Text] [Related]
29. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
30. [Cholesterol crystal embolisms due to systemic thrombolysis of an acute myocardial infarct].
Diethelm A; Vorburger C; Anabitarte M; Haag E
Schweiz Med Wochenschr; 1994 Aug; 124(33):1437-41. PubMed ID: 7939511
[TBL] [Abstract][Full Text] [Related]
31. [Local thrombolytic treatment of spontaneous intracerebral hemorrhage with plasminogen activator (rt-PA). Indications and limits].
Schaller C; Rohde V; Hassler W
Nervenarzt; 1995 Oct; 66(10):792. PubMed ID: 7501098
[No Abstract] [Full Text] [Related]
32. Intraventricular bleeding after the use of thrombolytics in a cocaine user.
LoVecchio F; Nelson L
Am J Emerg Med; 1996 Nov; 14(7):663-4. PubMed ID: 8906766
[TBL] [Abstract][Full Text] [Related]
33. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of recombinant tissue-type plasminogen activator thrombolysis and primary coronary stenting after acute myocardial infarction.
Chen B; Wang W; Zhao H; Hu D; Xu C; Zhao M; Lu M; Liu J; Wu C
Chin Med J (Engl); 2003 Jan; 116(1):142-4. PubMed ID: 12667408
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).
Kandzari DE; Granger CB; Simoons ML; White HD; Simes J; Mahaffey KW; Gore J; Weaver WD; Longstreth WT; Stebbins A; Lee KL; Califf RM; Topol EJ;
Am J Cardiol; 2004 Feb; 93(4):458-61. PubMed ID: 14969623
[TBL] [Abstract][Full Text] [Related]
36. [Pulmonary hemorrhage after thrombolysis in acute myocardial infarction].
Rodríguez Blanco VM; Barriales Alvarez V; Morís de la Tassa C
An Med Interna; 1996 Oct; 13(10):514-5. PubMed ID: 9019207
[No Abstract] [Full Text] [Related]
37. [Bilateral intracranial hemorrhage following thrombolytic therapy with alteplase (rTPA) in acute myocardial infarction].
Arbol Linde F; Marcos Sánchez F; Merlo González V; Simón Martín A; Quintana Díaz M; López Onega P
An Med Interna; 2002 Nov; 19(11):605-6. PubMed ID: 12522906
[No Abstract] [Full Text] [Related]
38. [Myocardial infarction, late fibrinolysis and resolving cerebral embolism].
Lescure M; Lagorce P; Caussanel JP; Malbec M
Ann Cardiol Angeiol (Paris); 1993 Jan; 42(1):25-7. PubMed ID: 8480981
[TBL] [Abstract][Full Text] [Related]
39. Thyroid hemorrhage after thrombolytic therapy for acute myocardial infarction.
Chia PL
J Cardiovasc Med (Hagerstown); 2008 Sep; 9(9):935-6. PubMed ID: 18695434
[TBL] [Abstract][Full Text] [Related]
40. Spontaneous hemarthrosis following fibrinolytic therapy for acute myocardial infarction: a case report and literature review.
Ramadan MM; Khan IS; Mahdi O
Am J Case Rep; 2014 Nov; 15():514-7. PubMed ID: 25417208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]